Accession Number:

ADA411291

Title:

Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin

Descriptive Note:

Final rept. 23 Sep 1996-30 Sep 2001

Corporate Author:

M D ANDERSON CANCER CENTER HOUSTON TX

Personal Author(s):

Report Date:

2001-10-01

Pagination or Media Count:

6.0

Abstract:

We studied the toxicity and antitumor activity of Liposomal-Annamycin in patients with metastatic breast carcinoma. Sixteen patients were treated. Toxicity was mild and consisted mostly of bone marrow suppression, particularly granulocytopenia. Non- hematological toxicity was less than what is usually seen with other anthracyclines. No responses were seen.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE